Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Perfusion imaging and clinical outcome in acute ischemic stroke with large core. Annals of neurology Seners, P., Oppenheim, C., Turc, G., Albucher, J., Guenego, A., Raposo, N., Christensen, S., Calviere, L., Viguier, A., Darcourt, J., Januel, A., Mlynash, M., Sommet, A., Thalamas, C., Sibon, I., Rousseau, V., Tourdias, T., Menegon, P., Bonneville, F., Mazighi, M., Charron, S., Legrand, L., Cognard, C., Albers, G. W., Baron, J., Olivot, J., FRAME investigators, Chollet, F., Fontaine, L., Barbieux, M., Michelozzi, C., Tall, P., Caparros, F., Pouzet, B., Calvas, F., Galitzki, M., Drif, A., Renou, P., Rouanet, F., Berge, J., Marnat, G., Menegon, P., Lucas, L., Coignon, C., Sagnier, S., Debruxelle, S., Ledure, S. 2021

Abstract

OBJECTIVE: Mechanical thrombectomy (MT) is not recommended for acute stroke with large vessel occlusion (LVO) and a large volume of irreversibly injured tissue (core). Perfusion imaging may identify a subset of patients with large core who benefit from MT.METHODS: We compared two cohorts of LVO-related patients with large core (>50ml on diffusion-weighted-imaging or CT-perfusion using RAPID), available perfusion imaging, and treated within 6hrs from onset by either MT+Best Medical Management (BMM) in one prospective study, or BMM alone in the pre-MT era from a prospective registry. Primary outcome was 90-day modified Rankin Scale=2. We searched for an interaction between treatment group and amount of penumbra as estimated by the mismatch ratio (MMRatio=critical hypoperfusion/core volume).RESULTS: Overall, 107 patients were included (56 MT+BMM+51 BMM): Mean age was 68±15yrs, median core volume 99ml (IQR: 72-131) and MMRatio 1.4 (IQR: 1.0-1.9). Baseline clinical and radiological variables were similar between the 2 groups, except for a higher intravenous thrombolysis rate in the BMM group. The MMRatio strongly modified the clinical outcome following MT (Pinteraction <0.001 for continuous MMRatio); MT was associated with a higher rate of good outcome in patients with, but not in those without, MMRatio>1.2 (adjusted OR [95%CI]=6.8 [1.7-27.0] vs. 0.7 [0.1-6.2], respectively). Similar findings were present for MMRatio=1.8 in the subgroup with core=70ml. Parenchymal hemorrhage on follow-up imaging was more frequent in the MT+BMM group regardless of the MMRatio.INTERPRETATION: Perfusion imaging may help select which patients with large core should be considered for MT. Randomized studies are warranted. This article is protected by copyright. All rights reserved.

View details for DOI 10.1002/ana.26152

View details for PubMedID 34216396